Cargando…
Evaluation of response to stereotactic radiosurgery in patients with radioresistant brain metastases
PURPOSE: Renal cell carcinoma (RCC) and melanoma have been considered ‘radioresistant’ due to the fact that they do not respond to conventionally fractionated radiation therapy. Stereotactic radiosurgery (SRS) provides high-dose radiation to a defined target volume and a limited number of studies ha...
Autores principales: | Sayan, Mutlay, Zoto Mustafayev, Teuta, Sahin, Bilgehan, Kefelioglu, Erva Seyma Sare, Wang, Shang-Jui, Kurup, Varsha, Balmuk, Aykut, Gungor, Gorkem, Ohri, Nisha, Weiner, Joseph, Ozyar, Enis, Atalar, Banu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Radiation Oncology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952719/ https://www.ncbi.nlm.nih.gov/pubmed/31918464 http://dx.doi.org/10.3857/roj.2019.00409 |
Ejemplares similares
-
Management of symptomatic radiation necrosis after stereotactic radiosurgery and clinical factors for treatment response
por: Sayan, Mutlay, et al.
Publicado: (2020) -
Magnetic Resonance–Guided Radiation Therapy to Boost Cervical Cancer When Brachytherapy Is Not Available: A Case Report
por: Sayan, Mutlay, et al.
Publicado: (2020) -
Patient-Reported Tolerance of Magnetic Resonance-Guided Radiation Therapy
por: Sayan, Mutlay, et al.
Publicado: (2020) -
Non-small Cell Lung Cancer with Multiple Brain Metastases Treated with Radiosurgery and Erlotinib: A Case Report
por: Sahin, Bilgehan, et al.
Publicado: (2017) -
First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience
por: Sahin, Bilgehan, et al.
Publicado: (2019)